oral glp-1 agonists New Guidelines for Type 2 Diabetes in 2025 Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Hepatology 41(6):13131321
Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity
Intestinal dysbiosis can also impair short-chain fatty acid production, which is important for gut barrier integrity, pancreatic cell proliferation, and insulin biosynthesis (22, 23)
CNS Drugs
This vascular dysfunction may cause the development of cerebral amyloid angiopathy and may contribute to the neurodegenerative processes observed in AD [17]
